Evidence map›Paper›PMID 41883186›Full record

ArticleJournal of the National Cancer Institute2026

Declines in cervical cancer incidence among young women in the United States.

Sameer Vali Gopalani, Jin Qin, Manxia Wu, Virginia Senkomago

Abstract read
In one paragraph

Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Sameer Vali GopalaniDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0003-0611-305X
Jin QinDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-9478-4218
Manxia WuDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0001-6467-9778
Virginia SenkomagoDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, United States.ORCID 0000-0002-9291-8016

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

We calculated age-standardized cervical cancer incidence rates and trends by histologic type among women aged 15-29 years, using cancer registry data covering approximately 99% of the US population. We examined differences in incidence rates from the earliest to the most recent study period and quantified changes over time using joinpoint regression. Incidence rates for cervical squamous cell carcinoma (SCC) and adenocarcinoma (AC) decreased significantly during 1999-2022 in all age groups (15-20, 21-24, 25-29 years). Among women aged 15-20 years, cervical SCC rates were stable from 1999 to 2010 but declined substantially by 24.2% (95% confidence interval = -44.4 to -18.0) each year from 2010 to 2022, with only a few cases reported during 2017-2022. These findings show that cervical cancer incidence has declined among adolescents and young adult women in the United States, particularly in more recent years, highlighting the population-level impact of cervical cancer prevention measures.

Indexed as

AdenocarcinomaCarcinoma, Squamous CellUterine Cervical NeoplasmsAdolescentAdultFemaleHumansIncidenceRegistriesSEER ProgramUnited StatesYoung Adult

Identifiers

PMID41883186
PMCPMC13108666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.